Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency [3]

Gut

Volumn 52, Issue 6, 2003, Pages 914-

  Ichikawa, T ^a   Hamasaki, K ^a   Ishikawa, H ^a   Ejima, E ^a   Eguchi, K ^a   Nakao, K ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; FATTY LIVER; GROWTH HORMONE DEFICIENCY; HEPATITIS; HUMAN; LETTER; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SYNDROME X;

ADULT; FATTY LIVER; HEPATITIS; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0038522807     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.6.914     Document Type: Letter

References (4)

1. Jahannsson G, Bengtsson BA. Growth hormone and the metabolic syndrome. J Endocrinol Invest 1999;22:41-6.
2. Willner IR, Waters B, Patil SR, et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001;96:2957-61.
3. Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-17.
4. Ogawa Y, Murata Y, Nishioka A, et al. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 1998;351:725.